Skip to main content
رجوع
FSPKF logo

Fisher & Paykel Healthcare Corporation Limited

جودة البيانات: 100%
FSPKF
OTC Healthcare Medical - Instruments & Supplies
KWD 22.31
▼ KWD 1.79 (-7.44%)
القيمة السوقية: 13.10B
نطاق اليوم
KWD 22.31 KWD 22.31
نطاق 52 أسبوعًا
KWD 16.35 KWD 25.69
حجم التداول
252
متوسط 50 يوم / 200 يوم
KWD 21.51 / KWD 20.84
الإغلاق السابق
KWD 22.31

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 34.7 0.4
P/B 6.9 2.9
ROE % 20.7 3.8
Net Margin % 29.5 3.9
Rev Growth 5Y % -10.0 10.0
D/E 0.1 0.2

السعر المستهدف للمحللين

Hold
KWD 23.650 +6.0%
Low: KWD 21.300 High: KWD 26.000
مكرر الربحية المستقبلي
28.2
ربحية السهم المستقبلية
KWD 0.791
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
2.3 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 0.126
KWD 0.124 – KWD 0.129
3.3 B 1
FY2029 KWD 1.252
KWD 1.224 – KWD 1.281
3.1 B 1
FY2028 KWD 1.068
KWD 1.045 – KWD 1.093
2.8 B 1

النقاط الرئيسية

Revenue declined -9.96% annually over 5 years
Earnings grew 184.46% over the past year
ROE of 20.67% indicates high profitability
Net margin of 29.46% shows strong profitability
Debt/Equity of 0.08 — conservative balance sheet
Generating 445.60M in free cash flow

النمو

Revenue Growth (5Y)
-9.96%
Revenue (1Y)-27.18%
Earnings (1Y)184.46%
FCF Growth (3Y)307.00%

الجودة

Return on Equity
20.67%
ROIC-13.62%
Net Margin29.46%
Op. Margin-28.98%

الأمان

Debt / Equity
0.08
Current Ratio1.87
Interest Coverage-33.42

التقييم

P/E Ratio
34.73
P/B Ratio6.93
EV/EBITDAN/A
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -27.18% Revenue Growth (3Y) -10.23%
Earnings Growth (1Y) 184.46% Earnings Growth (3Y) 22.76%
Revenue Growth (5Y) -9.96% Earnings Growth (5Y) -7.90%
Profitability
Revenue (TTM) 1.28B Net Income (TTM) 377.20M
ROE 20.67% ROA 14.79%
Gross Margin 41.41% Operating Margin -28.98%
Net Margin 29.46% Free Cash Flow (TTM) 445.60M
ROIC -13.62% FCF Growth (3Y) 307.00%
Safety
Debt / Equity 0.08 Current Ratio 1.87
Interest Coverage -33.42 Dividend Yield 0.01%
Valuation
P/E Ratio 34.73 P/B Ratio 6.93
P/S Ratio 10.23 PEG Ratio 0.26
EV/EBITDA N/A Dividend Yield 0.01%
Market Cap 13.10B Enterprise Value 12.99B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.28B 1.76B 1.59B 1.64B 1.95B
Net Income 377.20M 132.60M 250.30M 376.90M 524.20M
EPS (Diluted) 0.64 0.23 0.43 0.65 0.91
Gross Profit 530.20M 1.06B 945.90M 1.01B 1.22B
Operating Income -371.00M 254.40M 334.70M 509.10M 723.20M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.55B 2.28B 2.20B 2.11B 2.08B
Total Liabilities 660.40M 522.60M 451.10M 427.30M 554.10M
Shareholders' Equity 1.89B 1.76B 1.75B 1.68B 1.52B
Total Debt 153.30M 189.10M 145.80M 104.30M 118.40M
Cash & Equivalents 264.50M 82.00M 121.00M 89.90M 97.30M
Current Assets 935.40M 704.90M 774.20M 887.90M 920.00M
Current Liabilities 500.40M 385.00M 289.80M 303.90M 427.50M